Literature DB >> 18003900

3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis.

Tomoko Hayashi1, Ji-Hun Mo, Xing Gong, Cyprian Rossetto, Angela Jang, Lucinda Beck, Gregory I Elliott, Irina Kufareva, Ruben Abagyan, David H Broide, Jongdae Lee, Eyal Raz.   

Abstract

3-Hydroxyanthranilic acid (HAA), a compound generated during tryptophan metabolism initiated by indoleamine 2,3-dioxygenase, is known to induce T cell death, but its molecular target is not known. Here we report that HAA inhibits NF-kappaB activation upon T cell antigen receptor engagement by specifically targeting PDK1. Inhibition of NF-kappaB by HAA leads to dysfunction and cell death of activated Th2 cells, which in turn suppresses experimental asthma. Inhibition of NF-kappaB and induction of apoptosis is specific to CD4 T cells because HAA does not inhibit NF-kappaB activation or induce cell death upon Toll-like receptor 4 stimulation in dendritic cells. Thus, HAA is a natural inhibitor that restrains T cell expansion and activation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18003900      PMCID: PMC2141826          DOI: 10.1073/pnas.0709261104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  TAK1 regulates multiple protein kinase cascades activated by bacterial lipopolysaccharide.

Authors:  J Lee; L Mira-Arbibe; R J Ulevitch
Journal:  J Leukoc Biol       Date:  2000-12       Impact factor: 4.962

2.  A novel functional interaction between Vav and PKCtheta is required for TCR-induced T cell activation.

Authors:  M Villalba; N Coudronniere; M Deckert; E Teixeiro; P Mas; A Altman
Journal:  Immunity       Date:  2000-02       Impact factor: 31.745

3.  Systemic administration of immunostimulatory DNA sequences mediates reversible inhibition of Th2 responses in a mouse model of asthma.

Authors:  D H Broide; G Stachnick; D Castaneda; J Nayar; M Miller; J Y Cho; M Roman; J Zubeldia; T Hayashi; E Raz; T Hyashi
Journal:  J Clin Immunol       Date:  2001-05       Impact factor: 8.317

4.  3-Hydroxyanthranilic acid, an L-tryptophan metabolite, induces apoptosis in monocyte-derived cells stimulated by interferon-gamma.

Authors:  T Morita; K Saito; M Takemura; N Maekawa; S Fujigaki; H Fujii; H Wada; S Takeuchi; A Noma; M Seishima
Journal:  Ann Clin Biochem       Date:  2001-05       Impact factor: 2.057

5.  Identification of tyrosine phosphorylation sites on 3-phosphoinositide-dependent protein kinase-1 and their role in regulating kinase activity.

Authors:  J Park; M M Hill; D Hess; D P Brazil; J Hofsteenge; B A Hemmings
Journal:  J Biol Chem       Date:  2001-07-31       Impact factor: 5.157

6.  Tryptophan degradation by human placental indoleamine 2,3-dioxygenase regulates lymphocyte proliferation.

Authors:  Y Kudo; C A Boyd; I L Sargent; C W Redman
Journal:  J Physiol       Date:  2001-08-15       Impact factor: 5.182

7.  Substitution of the autophosphorylation site Thr516 with a negatively charged residue confers constitutive activity to mouse 3-phosphoinositide-dependent protein kinase-1 in cells.

Authors:  Michael J Wick; KeriLyn R Wick; Hui Chen; Huili He; Lily Q Dong; Michael J Quon; Feng Liu
Journal:  J Biol Chem       Date:  2002-02-27       Impact factor: 5.157

8.  Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis.

Authors:  Kenichi Sakurai; Jian-Ping Zou; Jolynne R Tschetter; Jerrold M Ward; Gene M Shearer
Journal:  J Neuroimmunol       Date:  2002-08       Impact factor: 3.478

9.  Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes.

Authors:  K Y Vermaelen; I Carro-Muino; B N Lambrecht; R A Pauwels
Journal:  J Exp Med       Date:  2001-01-01       Impact factor: 14.307

10.  Notch-induced T cell development requires phosphoinositide-dependent kinase 1.

Authors:  April P Kelly; David K Finlay; Heather J Hinton; Rosie G Clarke; Emma Fiorini; Freddy Radtke; Doreen A Cantrell
Journal:  EMBO J       Date:  2007-06-28       Impact factor: 11.598

View more
  56 in total

1.  Recent advances in immunotherapy of allergic rhinitis.

Authors:  Chul Hee Lee; Ji-Hun Mo
Journal:  Curr Allergy Asthma Rep       Date:  2008-07       Impact factor: 4.806

Review 2.  Modulating Tumor Immunology by Inhibiting Indoleamine 2,3-Dioxygenase (IDO): Recent Developments and First Clinical Experiences.

Authors:  Diwakar Davar; Nathan Bahary
Journal:  Target Oncol       Date:  2018-04       Impact factor: 4.493

Review 3.  Amino acid catabolism: a pivotal regulator of innate and adaptive immunity.

Authors:  Tracy L McGaha; Lei Huang; Henrique Lemos; Richard Metz; Mario Mautino; George C Prendergast; Andrew L Mellor
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

4.  Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease.

Authors:  David Favre; Jeff Mold; Peter W Hunt; Bittoo Kanwar; P'ng Loke; Lillian Seu; Jason D Barbour; Margaret M Lowe; Anura Jayawardene; Francesca Aweeka; Yong Huang; Daniel C Douek; Jason M Brenchley; Jeffrey N Martin; Frederick M Hecht; Steven G Deeks; Joseph M McCune
Journal:  Sci Transl Med       Date:  2010-05-19       Impact factor: 17.956

Review 5.  Dendritic cells, indoleamine 2,3 dioxygenase and acquired immune privilege.

Authors:  Lei Huang; Babak Baban; Burles A Johnson; Andrew L Mellor
Journal:  Int Rev Immunol       Date:  2010-04       Impact factor: 5.311

6.  Neurotransmitter signalling via NMDA receptors leads to decreased T helper type 1-like and enhanced T helper type 2-like immune balance in humans.

Authors:  Kanami Orihara; Solomon O Odemuyiwa; William P Stefura; Ramses Ilarraza; Kent T HayGlass; Redwan Moqbel
Journal:  Immunology       Date:  2017-11-03       Impact factor: 7.397

Review 7.  Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy.

Authors:  Aitziber Buqué; Norma Bloy; Fernando Aranda; Isabelle Cremer; Alexander Eggermont; Wolf Hervé Fridman; Jitka Fucikova; Jérôme Galon; Radek Spisek; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2016-03-10       Impact factor: 8.110

8.  Host interleukin 6 production regulates inflammation but not tryptophan metabolism in the brain during murine GVHD.

Authors:  Ludovic Belle; Vivian Zhou; Kara L Stuhr; Margaret Beatka; Emily M Siebers; Jennifer M Knight; Michael W Lawlor; Casey Weaver; Misato Hashizume; Cecilia J Hillard; William R Drobyski
Journal:  JCI Insight       Date:  2017-07-20

Review 9.  IDO: a double-edged sword for T(H)1/T(H)2 regulation.

Authors:  Hui Xu; Guang-Xian Zhang; Bogoljub Ciric; Abdolmohamad Rostami
Journal:  Immunol Lett       Date:  2008-09-29       Impact factor: 3.685

Review 10.  O death where is thy sting? Immunologic tolerance to apoptotic self.

Authors:  Buvana Ravishankar; Tracy L McGaha
Journal:  Cell Mol Life Sci       Date:  2013-02-03       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.